Phathom Pharmaceuticals, Inc. short interest in 2021
In 2021, Phathom Pharmaceuticals, Inc.'s disclosed short interest ran from 1.97% of shares outstanding on 15 Jan 2021 to 14.04% on 31 Dec 2021, a change of +12.07 percentage points. The year's high was 14.04% on 31 Dec 2021 and its low 1.44% on 26 Feb 2021, averaging 4.92% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 36.67 days on 31 Dec 2021. Full history: Phathom Pharmaceuticals, Inc..
Cite this page
By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2021 in figures
- Start of year
- 1.97% (15 Jan 2021)
- End of year
- 14.04% (31 Dec 2021)
- Change
- +12.07 pp
- High
- 14.04% (31 Dec 2021)
- Low
- 1.44% (26 Feb 2021)
- Average
- 4.92%
- Highest days to cover
- 36.67 (31 Dec 2021)
- SEC filings marked
- 9
Every report in 2021
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2021 | 1.97% | 5.12 | |
| 29 Jan 2021 | 1.66% | 5.22 | |
| 12 Feb 2021 | 1.63% | 6.80 | |
| 26 Feb 2021 | 1.44% | 4.18 | |
| 15 Mar 2021 | 1.89% | 6.90 | |
| 31 Mar 2021 | 1.81% | 5.83 | 10-K filed, results (8-K) |
| 15 Apr 2021 | 1.93% | 7.13 | |
| 30 Apr 2021 | 2.23% | 10.13 | |
| 14 May 2021 | 3.11% | 10.19 | 10-Q filed, results (8-K) |
| 28 May 2021 | 3.19% | 10.35 | |
| 15 Jun 2021 | 3.30% | 13.53 | |
| 30 Jun 2021 | 3.94% | 6.87 | |
| 15 Jul 2021 | 3.96% | 19.67 | |
| 30 Jul 2021 | 4.15% | 18.94 | |
| 13 Aug 2021 | 5.05% | 16.95 | 10-Q filed, results (8-K) |
| 31 Aug 2021 | 5.10% | 20.49 | |
| 15 Sep 2021 | 4.45% | 18.94 | |
| 30 Sep 2021 | 4.82% | 16.95 | |
| 15 Oct 2021 | 5.65% | 25.00 | |
| 29 Oct 2021 | 11.33% | 8.46 | results (8-K) |
| 15 Nov 2021 | 12.06% | 17.51 | 10-Q filed, results (8-K) |
| 30 Nov 2021 | 9.51% | 16.50 | |
| 15 Dec 2021 | 9.77% | 28.35 | |
| 31 Dec 2021 | 14.04% | 36.67 |
See also: Phathom Pharmaceuticals, Inc.'s full history · most shorted US stocks of 2021 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.